The 4 references in paper A. Kolbin S., A. Prasolov V., E. Maksimkina A., Yu. Balykina E., Z. Golant M., Yu. Polushin S., A. Kurylev A., I. Vilyum A., А. Колбин С., А. Прасолов В., Е. Максимкина А., Ю. Балыкина Е., З. Голант М., Ю. Полушин С., А. Курылев А., И. Вилюм А. (2016) “Модели анализа включений лекарственных средств в ограничительные перечни (на примере ЖНВЛП) 2016 г. // MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016” / spz:neicon:pharmacoeconomics:y:2016:i:1:p:34-38

1
Vlasov V.V., Plavinskii S.L. Possible drug supply to Russia: Lessons from Europe and around the world [Varianty lekarstvennogo obespecheniya dlya Rossii: uroki stran Evropy i vsego mira (in Russian)]. Moscow. 2013; 107 s.
(check this in PDF content)
2
Government Decree of Russia from 28.08.2014 N 871 "On Approval of Regulations for the formation of lists of drugs for medical use and minimal assortment of drugs needed for medical care."Consultant Plus Database. URL: http://www.consultant.ru/document/cons_doc_ LAW_167999/. (accessed: 05.01.2016).
(check this in PDF content)
3
Prasolov A.V., Kolbin A.S., Maksimkina E.A., Golant Z.M., Polushin Yu.S., Kurylev A.A., Vilyum I.A., Balykina Yu.E. Remedium. 2015; 58-63.
(check this in PDF content)
4
The order of the Russian Federation from 12/26/2015 number 2724-p. The official internet-portal of legal information. URL: http://publication.pravo.gov.ru/Document/View/0001201601040062. (accessed: 05.01.2016).
(check this in PDF content)